Interesting CELG Put And Call Options For February 28th

Investors in Celgene Corp. ( CELG) saw new options begin trading today, for the February 28th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CELG options chain for the new February 28th contracts and identified one put and one call contract of particular interest.

The put contract at the $167.50 strike price has a current bid of $5.60. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $167.50, but will also collect the premium, putting the cost basis of the shares at $161.90 (before broker commissions). To an investor already interested in purchasing shares of CELG, that could represent an attractive alternative to paying $168.38/share today.

Because the $167.50 strike represents an approximate 1% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 54%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 3.34% return on the cash commitment, or 33.90% annualized — at Stock Options Channel we call this the YieldBoost.

Top YieldBoost Puts of the Nasdaq 100 »

Below is a chart showing the trailing twelve month trading history for Celgene Corp., and highlighting in green where the $167.50 strike is located relative to that history:

If you liked this article you might like

How I've Prepared for Hurricane Irma -- and a Market Pullback

How I'm Prepared for Irma -- and a Pullback

Juno, bluebird In Focus as Targets Following Gilead-Kite Aquisition

Apple Is the Tom Brady of Stocks: Cramer's 'Mad Money' Recap (Thursday 8/31/17)

Cramer: Fantasy Shmantasy -- Let's Get Real With These Stock Picks